These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 19251712

  • 21. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
    Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Rodríguez-Pérez JM, Zuñiga J, Granados J.
    Immunol Lett; 2004 Aug 15; 95(1):31-5. PubMed ID: 15325795
    [Abstract] [Full Text] [Related]

  • 22. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y, Matsumoto K, Negoro K, Takagi S, Takahashi S, Hiwatashi N, Shimosegawa T.
    Dis Colon Rectum; 2003 Oct 15; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [Abstract] [Full Text] [Related]

  • 23. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.
    Bittencourt PL, Farias AQ, Porta G, Cançado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ.
    J Clin Gastroenterol; 2008 Mar 15; 42(3):300-5. PubMed ID: 18223493
    [Abstract] [Full Text] [Related]

  • 24. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J, Török HP, Tonenchi L, Wetzke M, Beynon V, Teshome MY, Cotofana S, Schiemann U, Griga T, Klein W, Epplen JT, Folwaczny C, Folwaczny M, Mussack T, Weiss EH.
    Int Immunol; 2007 May 15; 19(5):621-6. PubMed ID: 17446213
    [Abstract] [Full Text] [Related]

  • 25. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
    Yang H, Rotter JI, Toyoda H, Landers C, Tyran D, McElree CK, Targan SR.
    J Clin Invest; 1993 Aug 15; 92(2):1080-4. PubMed ID: 8349790
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
    Tedde A, Laura Putignano A, Bagnoli S, Congregati C, Milla M, Sorbi S, Genuardi M, Papi L.
    Scand J Gastroenterol; 2008 Aug 15; 43(6):712-8. PubMed ID: 18569989
    [Abstract] [Full Text] [Related]

  • 27. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 15; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 28. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P, Peters B, Meyer F, Schubert D, Bohr UR, Malfertheiner P, Lippert H, Silver AR, Roessner A, Schneider-Stock R.
    Pathol Res Pract; 2010 Sep 15; 206(9):616-24. PubMed ID: 20630662
    [Abstract] [Full Text] [Related]

  • 29. [The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases].
    Matri S, Boubaker J, Hamzaoui S, Bardi R, Ayed K, Filali A.
    Tunis Med; 2003 May 15; 81(5):289-94. PubMed ID: 12934447
    [Abstract] [Full Text] [Related]

  • 30. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M, Schmid KW, Senninger N, Schürmann G.
    World J Surg; 2002 Mar 15; 26(3):390-6. PubMed ID: 11865380
    [Abstract] [Full Text] [Related]

  • 31. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.
    Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, Slavin RG, Bellone CJ.
    J Allergy Clin Immunol; 2000 Oct 15; 106(4):723-9. PubMed ID: 11031343
    [Abstract] [Full Text] [Related]

  • 32. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
    Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM, Meltzer SJ.
    Cancer Res; 2002 Feb 15; 62(4):1148-51. PubMed ID: 11861396
    [Abstract] [Full Text] [Related]

  • 33. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
    Okada Y, Yamazaki K, Umeno J, Takahashi A, Kumasaka N, Ashikawa K, Aoi T, Takazoe M, Matsui T, Hirano A, Matsumoto T, Kamatani N, Nakamura Y, Yamamoto K, Kubo M.
    Gastroenterology; 2011 Sep 15; 141(3):864-871.e1-5. PubMed ID: 21699788
    [Abstract] [Full Text] [Related]

  • 34. MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population.
    Ding Y, Xia B, Lü M, Zhang Y, Li J, Ye M, Luo H, Yu J, Zhang X, Tan J.
    Clin Exp Immunol; 2005 Oct 15; 142(1):193-8. PubMed ID: 16178876
    [Abstract] [Full Text] [Related]

  • 35. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.
    Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude CJ, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK.
    Am J Gastroenterol; 2010 Feb 15; 105(2):395-402. PubMed ID: 19861958
    [Abstract] [Full Text] [Related]

  • 36. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
    Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H, Iwata M, Kamiya Y, Nagasaka M, Takahama K, Watanabe M, Hirata I, Nakano H.
    J Gastroenterol Hepatol; 2007 Jun 15; 22(6):925-9. PubMed ID: 17565650
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R.
    Acta Gastroenterol Latinoam; 2008 Mar 15; 38(1):26-33. PubMed ID: 18533354
    [Abstract] [Full Text] [Related]

  • 38. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
    Gonzalez-Gay MA, Rueda B, Vilchez JR, Lopez-Nevot MA, Robledo G, Ruiz MP, Fernández O, Garcia-Porrua C, Gonzalez-Escribano MF, Martín J.
    Rheumatology (Oxford); 2007 Mar 15; 46(3):431-4. PubMed ID: 17003171
    [Abstract] [Full Text] [Related]

  • 39. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis.
    Tominaga K, Fujii S, Mukawa K, Fujita M, Ichikawa K, Tomita S, Imai Y, Kanke K, Ono Y, Terano A, Hiraishi H, Fujimori T.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8880-5. PubMed ID: 16361578
    [Abstract] [Full Text] [Related]

  • 40. Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients.
    Sebastiani GD, Bellisai F, Caudai C, Rottoli P, Valensin PE, Pippi L, Morozzi G, Porciello G, Donvito A, Bilenchi R, Giannini F, Galeazzi M.
    J Biol Regul Homeost Agents; 2005 Dec 15; 19(1-2):17-22. PubMed ID: 16180280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.